Compositions comprising darunavir, cobicistat, emtricitabine and tenofovir alafenamide for use in the treatment of HIV

• 收藏
• 分享

专利权人:

Janssen Sciences Ireland Unlimited Company;Gilead Sciences, Inc.

发明人:

BOVEN, Katia,DE SMEDT, Goedele,DRIESEN, Regina,HENRIST, Dominiek,KAUWENBERGHS, Greet,MATHUR, Sandeep,MCCALLISTER, Scott,MERTENS, Roel,NETTLES, Richard,OPSOMER, Magda,PRYZ, William,ZIA, Vahid

申请号：

AU2018304373

公开号：

AU2018304373A1

申请日:

2018.07.19

申请国别(地区):

AU

年份:

2020

代理人:

摘要：

The disclosure is directed to methods of treating subjects infected with HIV, once daily, with single unit dosage forms that include darunavir (or a hydrate or solvate thereof), cobicistat, emtricitabine, and a tenofovir prodrug, or salt thereof.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/